Pharmaceutical Press
Pharmaceutical Press is the Royal College of Pharmacy's publishing and knowledge-services arm, providing evidence-based pharmaceutical reference content via the MedicinesComplete digital platform, data licensing, and print publications to healthcare professionals and institutions globally.
- Company typePrivate
- Founded1841
- HeadquartersLondon, United Kingdom
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Pharmaceutical Press does
Pharmaceutical Press is the publishing and knowledge-services arm of the Royal College of Pharmacy, producing evidence-based pharmaceutical reference content for healthcare professionals globally. Founded in 1841 and headquartered in London, the company operates as a private limited company (Company Number 07165037) and is wholly owned by the Royal College of Pharmacy. It holds ISO 9001 certification and runs an editorial function staffed by clinical and scientific writers who curate a proprietary drug knowledge base.
Pharmaceutical Press firmographics
Firmographics- Name
- Pharmaceutical Press
- Legal name
- Pharmaceutical Press Limited
- Website
- https://pharmpress.com
- Company type
- Private
- Founded year
- 1841
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Pharmaceutical Press is the Royal College of Pharmacy's publishing and knowledge-services arm, providing evidence-based pharmaceutical reference content via the MedicinesComplete digital platform, data licensing, and print publications to healthcare professionals and institutions globally.
- Ownership category
- akta.pro rank
Pharmaceutical Press industry classification
Industry- Product category
- Pharmaceutical Reference Publishing
- NAICS
- Book Publishers (513130)
- SIC
- Books: Publishing Or Publishing & Printing (2731)
- akta.pro primary industry
- Medical & Clinical Reference (Physicians, Nursing, Allied Health) (EDAGAGAA)
- akta.pro secondary industries
- Medical, Clinical & Biomedical Scholarly Publishing (EDAGAFAB), Medical Affairs Scientific Communications (MSL Support/Scientific Response) (HLAGALAF), Medical Writing & Publications (Clinical/Safety/HEOR) (HLAGALAG)
Keywords
Where Pharmaceutical Press is headquartered
LocationHeadquarters
- HQ city
- London
- HQ country
- United Kingdom
- HQ region
- Europe
Offices1 record
Markets served
Pharmaceutical Press business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- MedicinesComplete Subscriptions: Subscription-based access to pharmaceutical knowledge platform providing online access to reference materials including BNF, drug interaction checkers, and clinical guidelines. Available 24/7 with tiered access levels.
- Data Licensing: Licensing of pharmaceutical content for integration into third-party clinical decision support tools, applications, and digital health platforms
- Print Publications: Sale of printed pharmaceutical reference books and formulary publications through the online shop
Go-to-market motion1 record
Distribution channels5 records
Marketing channels9 records
Pharmaceutical Press product offering
Product offeringCore offering
Pharmaceutical Press publishes and licenses evidence-based pharmaceutical knowledge through the MedicinesComplete subscription platform, a portfolio of authoritative reference works (BNF, BNFC, Martindale, Stockley's, and others), and licensed data feeds integrated into third-party clinical decision support tools. Content is curated by expert editorial teams and delivered digitally, in print, or via API-style data licensing to healthcare, academic, and research customers globally.
Product overview
Pharmaceutical Press operates as a knowledge business providing evidence-based pharmaceutical information through two primary channels: the MedicinesComplete digital platform (a unified platform hosting multiple reference databases and clinical decision support tools) and licensed data feeds for integration into third-party clinical systems. The product portfolio consists of core reference titles (BNF, BNF for Children, Martindale, Stockley's), point-of-need tools (Drug Compatibility Checker, Drug Monitoring Checker, Stockley's Interactions Checker), specialist resources (Critical Illness, Drugs in Pregnancy and Lactation, Psychotropic Drug Directory), drug administration guides (ASHP Injectable Drug Information, Injectable Drugs Guide, Pediatric Injectable Drugs), legal and regulatory references (MHRA Orange and Green Guides, Dale and Appelbe's Pharmacy and Medicines Law), complementary medicine references, and specialist palliative care resources.
Differentiator
Problem solved
Functional benefit
Brands
- MedicinesComplete: Online platform providing access to Pharmaceutical Press's evidence-based pharmaceutical knowledge, integrated into clinical decision support tools.
Products and services
- MedicinesComplete
- British National Formulary (BNF)
- BNF for Children (BNFC)
- Martindale: The Complete Drug Reference
- Stockley's Drug Interactions
- Palliative Care Formulary
- Critical Illness
- Drugs in Pregnancy and Lactation
- Psychotropic Drug Directory
- ASHP Injectable Drug Information
- Injectable Drugs Guide
- Pediatric Injectable Drugs
- AHFS Drug Information
- Clarke's Analysis of Drugs and Poisons
- Electronic Medicines Compendium (emc)
- Kucers' the Use of Antibiotics
- Pharmaceutical Excipients
- Herbal Medicines and Dietary Supplements
- Stockley's Herbal Medicines Interactions
- Dale and Appelbe's Pharmacy and Medicines Law
- The MHRA Orange Guide
- The MHRA Green Guide
- Data Licensing
Quantifiable outcome
- Reduce harm from medication errors by making evidence-based pharmaceutical knowledge easily accessible
- +1 more outcomes
Companies that use Pharmaceutical Press
Customer profileNamed customers3 records
Segments7 records
Ideal customer profiles7 records
Pharmaceutical Press technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Pharmaceutical Press partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Royal College of PharmacycorePharmaceutical Press is the Royal College of Pharmacy's knowledge business. This is the core organizational relationship defining the company's authority and mission alignment with the professional pharmacy body.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
Pharmaceutical Press competitors and assessment
Company assessmentDirect peers
- First Databank (FDB): First Databank licenses drug knowledge (MedKnowledge, Drug Interactions) to EHR vendors, hospital systems and digital health platforms — directly competing with Pharmaceutical Press's data licensing feed for integration into clinical decision support tools.
- Wolters Kluwer Clinical Drug Information (Lexicomp, Medi-Span): Wolters Kluwer's clinical drug information unit (Lexicomp, Medi-Span, UpToDate) is the closest direct competitor, offering curated drug monographs, interaction checkers and point-of-care clinical decision support subscribed to by hospitals, pharmacists and EHR vendors globally.
- American Society of Health-System Pharmacists (ASHP) — AHFS: ASHP publishes AHFS Drug Information and ASHP Injectable Drug Information — titles Pharmaceutical Press itself distributes under license — making ASHP a peer as both publisher of authoritative US drug content and a competing professional-body reference.
- MIMS (Monthly Index of Medical Specialities): MIMS is a long-established UK/Asia-Pacific drug reference and interaction resource used by GPs, pharmacists and hospitals, comparable as a competing formulary-style drug reference aimed at the same UK and Commonwealth healthcare audience.
- Elsevier Clinical Pharmacology: Elsevier's Clinical Pharmacology product provides hospital and institutional drug reference and interaction checking integrated into EHR workflows, directly competing with MedicinesComplete on the same enterprise buyer and clinical decision support use case.
- IBM Watson Health / Merative Micromedex: Micromedex is an enterprise drug reference and clinical decision support product used by hospitals and pharmacists globally, comparable to MedicinesComplete in both content depth and the institutional buyer profile.
Broad incumbents
- UpToDate (Wolters Kluwer): UpToDate is a broader clinical decision support resource owned by Wolters Kluwer that includes drug information within a wider evidence-based clinical reference, competing for the same point-of-care pharmacist and prescriber budget against MedicinesComplete.
Emerging players
- DrugBank: DrugBank provides structured drug data and interaction datasets licensed into pharma, digital health and research platforms, representing an emerging, data-first competitor in the same clinical decision support content licensing space.
Others
- National Library of Medicine — DailyMed / MedlinePlus: NLM provides free federally curated drug labeling (DailyMed) and consumer health information that competes at the margins with paid reference offerings like Martindale and Electronic Medicines Compendium as a public-good alternative.
- Royal Pharmaceutical Society (RPS): The Royal Pharmaceutical Society is a UK professional body whose members overlap the same pharmacist audience Pharmaceutical Press serves; while not a direct product competitor, it shapes the professional context in which BNF and MedicinesComplete are adopted.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Pharmaceutical Press social profiles
Digital presencePharmaceutical Press compliance and trust
Trust signalCompliance1 record
Pharmaceutical Press financial estimates
Financial estimateRevenue estimate
Valuation estimate
Pharmaceutical Press leadership team
Management profileNumber of profiles
Pharmaceutical Press funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Pharmaceutical Press M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Pharmaceutical Press
What does Pharmaceutical Press do?
Pharmaceutical Press publishes and licenses evidence-based pharmaceutical knowledge through the MedicinesComplete subscription platform, a portfolio of authoritative reference works (BNF, BNFC, Martindale, Stockley's, and others), and licensed data feeds integrated into third-party clinical decision support tools. Content is curated by expert editorial teams and delivered digitally, in print, or via API-style data licensing to healthcare, academic, and research customers globally.
Is Pharmaceutical Press a public or private company?
Pharmaceutical Press is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Pharmaceutical Press founded?
Pharmaceutical Press was founded in 1841. It employs 11 to 50 people.
Where is Pharmaceutical Press based?
Pharmaceutical Press is headquartered in London, United Kingdom, in the Europe region.
How does Pharmaceutical Press make money?
Three revenue lines are on record. MedicinesComplete Subscriptions are the primary driver. The others are data Licensing and print Publications.
Who are Pharmaceutical Press's main competitors?
Direct peers on record are First Databank (FDB), Wolters Kluwer Clinical Drug Information (Lexicomp, Medi-Span), American Society of Health-System Pharmacists (ASHP) — AHFS, MIMS (Monthly Index of Medical Specialities), Elsevier Clinical Pharmacology and IBM Watson Health / Merative Micromedex. UpToDate (Wolters Kluwer) is listed as a broad incumbent. DrugBank is listed as an emerging player. Others are National Library of Medicine — DailyMed / MedlinePlus and Royal Pharmaceutical Society (RPS).
Does Pharmaceutical Press have an API?
No public API is recorded for Pharmaceutical Press.
What industry is Pharmaceutical Press in?
Pharmaceutical Press's product category is Pharmaceutical Reference Publishing. Its primary akta.pro industry code is EDAGAGAA, Medical & Clinical Reference (Physicians, Nursing, Allied Health), with a secondary code of EDAGAFAB, Medical, Clinical & Biomedical Scholarly Publishing. Its NAICS code is 513130 and its SIC code is 2731.